Freestone Grove Partners LP Bio Rad Laboratories, Inc. Transaction History
Freestone Grove Partners LP
- $8.16 Trillion
- Q4 2024
A detailed history of Freestone Grove Partners LP transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Freestone Grove Partners LP holds 46,015 shares of BIO stock, worth $13.1 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
46,015Holding current value
$13.1 Million% of portfolio
0.19%Shares
1 transactions
Others Institutions Holding BIO
# of Institutions
476Shares Held
19.2MCall Options Held
15.7KPut Options Held
11.5K-
Vanguard Group Inc Valley Forge, PA1.92MShares$545 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$440 Million0.01% of portfolio
-
Wealthfront Advisers LLC1.04MShares$296 Million0.29% of portfolio
-
Veritas Asset Management LLP977KShares$277 Million3.36% of portfolio
-
Dimensional Fund Advisors LP Austin, TX746KShares$212 Million0.06% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.99B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...